CPM Market Economics: Navigating Rare Disease Costs, Pricing, and Patient-Centric Innovation The Central Pontine Myelinolysis (CPM) market operates in the unique economic landscape of rare diseases, where small patient pools, high R&D costs, and limited competition create complex pricing dynamics. For businesses, balancing profitability with patient access is critical to sustaining growth. This tension drives innovation in pricing models, product design, and partnerships, reshaping...